1. Home
  2. ORN vs BCYC Comparison

ORN vs BCYC Comparison

Compare ORN & BCYC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Orion Group Holdings Inc.

ORN

Orion Group Holdings Inc.

HOLD

Current Price

$10.88

Market Cap

411.7M

Sector

Industrials

ML Signal

HOLD

Logo Bicycle Therapeutics plc

BCYC

Bicycle Therapeutics plc

HOLD

Current Price

$4.31

Market Cap

360.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ORN
BCYC
Founded
1994
2009
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Military/Government/Technical
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
411.7M
360.7M
IPO Year
2007
2019

Fundamental Metrics

Financial Performance
Metric
ORN
BCYC
Price
$10.88
$4.31
Analyst Decision
Strong Buy
Buy
Analyst Count
4
10
Target Price
$16.25
$14.00
AVG Volume (30 Days)
424.4K
503.4K
Earning Date
03-03-2026
03-17-2026
Dividend Yield
N/A
N/A
EPS Growth
220.00
N/A
EPS
0.06
N/A
Revenue
$852,260,000.00
N/A
Revenue This Year
$8.50
N/A
Revenue Next Year
$7.83
$37.20
P/E Ratio
$181.33
N/A
Revenue Growth
7.01
N/A
52 Week Low
$4.64
$4.25
52 Week High
$15.00
$9.55

Technical Indicators

Market Signals
Indicator
ORN
BCYC
Relative Strength Index (RSI) 42.27 33.24
Support Level $9.85 N/A
Resistance Level $11.70 $7.14
Average True Range (ATR) 0.63 0.30
MACD 0.06 -0.02
Stochastic Oscillator 41.48 7.43

Price Performance

Historical Comparison
ORN
BCYC

About ORN Orion Group Holdings Inc.

Orion Group Holdings Inc is a specialty construction company serving the infrastructure, industrial, and building sectors, providing services both on and off the water in the continental United States, Alaska, Canada, and the Caribbean Basin through its marine segment and its concrete segment. Its marine segment provides construction and dredging services relating to marine transportation facility construction, marine pipeline construction, marine environmental structures, dredging of waterways, channels and ports, environmental dredging, design, and specialty services. The concrete segment generates maximum revenue and provides construction services for commercial, industrial, multi-family residential, and public projects, including the data center market.

About BCYC Bicycle Therapeutics plc

Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United States.

Share on Social Networks: